Sector and Industry ETFs

The taxonomy: who decides what "technology" means

The market's org chart is GICS (Global Industry Classification Standard, run jointly by MSCI and S&P): 11 sectors → 25 industry groups → 74 industries → 163 sub-industries (counts drift with revisions), assigning every listed company one home based on its principal business. FTSE's ICB is the parallel scheme in Russell/FTSE-land. Two properties matter for investors:

Classification is editorial, and it moves. The 2018 restructuring created the Communications Services sector and relocated Alphabet, Meta and Netflix out of Tech/Consumer overnight; Amazon sits in Consumer Discretionary, not Technology; payment giants were shifted from Tech to Financials in 2023. Consequence: a "Technology ETF" excludes several companies the world calls tech, sector histories splice differently across the 2018 seam, and any sector bet is partly a bet on a committee's definition of the theme. The factsheet's holdings list (Chapter 24), not the fund's name, tells you what you actually bought: this book's oldest rule, at its most necessary.

Sectors are not equal citizens. At mid-2020s weights, Information Technology alone is ~a quarter-plus of the S&P 500 while Materials, Utilities and Real Estate are low single digits each: "diversifying across sectors" equal-weight style is a large active bet against the market's structure, not a neutral stance.

The structural realities of sector funds

Concentration in a costume. A sector is a handful of giants plus a tail: uncapped, US Tech would be dominated by two names; Energy by two; the buyable funds therefore track capped variants (Chapter 40's 25/50-style rules for RIC/UCITS compliance), which still commonly hold 20%+ in the top two positions. Chapter 18's language applies verbatim: a sector ETF diversifies away single-company within-sector risk while deliberately retaining the concentrated sector bet: legitimate as a conscious satellite, never a diversifier.

The lineups differ by wrapper. US investors have the classic Select Sector SPDRs (S&P 500 sliced eleven ways, ~0.09%) and total-market sector funds; European investors get MSCI World/Europe sector UCITS funds (~0.18–0.30%) with global rather than US-only membership: same sector, different country mix, materially different funds. Industry-level products (semiconductors, banks, biotech) narrow further and shade into Chapter 47's thematic territory, where index construction gets more creative.

The rotation temptation, scored. Sector leadership rotates violently (energy: worst-to-first 2020→2022; tech's mirror image), which makes rotation strategies perennially marketed and persistently disappointing: the SPIVA-style evidence on tactical/rotation funds shows the familiar majority trailing simple benchmarks, and the retail flow data shows money arriving in each sector after its run: performance-chasing (Chapter 30, Mistake 1) with sharper tools. The honest statement: sectors are where timing skill would pay magnificently, and where the evidence says almost nobody has it.

Legitimate uses, precisely stated

• The researched tilt: a sized overweight based on an actual thesis (valuation work, structural analysis), run under Chapter 61's satellite caps with a written benchmark and exit condition. The tool fits the job; most users skip the thesis and keep the tool.
• Completing or offsetting: an employee loaded with tech compensation underweighting tech (or overweighting everything else) is using sector funds as risk management: arguably their best retail use. Similarly: adding the sector a home-country index lacks.
• Defensive tilting near spending horizons: shifting toward historically lower-beta sectors (utilities, staples, healthcare) as a deliberate, modest de-risking flavor: defensible, though Chapter 19's allocation dial does this job more directly and cheaply.
• Professional hedging/transition uses (pairing against single names, equitizing views): real, institutional, and mentioned so the products' existence makes sense: not homework for the reader.

A worked example

Two portfolios, same €10,000 into "healthcare conviction":

• Lena writes the thesis (demographics + a valuation screen), buys a global healthcare UCITS fund at 5% of her portfolio (satellite cap), notes the capped index's top-5 (~35%) and its 65% US weight, sets a review date and a benchmark (world index) in her policy. Two years later the tilt trails the world by 4%: her written exit condition hasn't triggered, the thesis stands, she holds: a position behaving as designed.
• Marc buys the same fund at 25% of his portfolio in January because it led last year's tables, discovers via a drawdown that two stocks drive it, and sells in the autumn 12% behind: not because healthcare failed, but because nothing was written down that could tell him what holding it was supposed to feel like.

Identical fund; the difference was everything around it: which is the entire sector-ETF story. The instrument is fine. The use cases are narrow. The paperwork is the strategy.